Unicycive Therapeutics (UNCY) Depreciation & Amortization (CF) (2022 - 2026)
Unicycive Therapeutics posted quarterly Depreciation & Amortization (CF) of $8000.0 for Q1 2026, little changed year-on-year from $8000.0 in Q1 2025, and down 20.0% on a QoQ basis from $10000.0 in Q4 2025.
Unicycive Therapeutics (UNCY) has 5 years of Depreciation & Amortization (CF) data on file, last reported at $8000.0 in Q1 2026.
- For the quarter ending Q1 2026, Depreciation & Amortization (CF) changed 0.0% year-over-year to $8000.0; the trailing twelve-month figure through Mar 2026 stood at $34000.0 (up 61.9% YoY), and the FY2025 full-year result was $34000.0, up 54.55% from the prior year.
- Depreciation & Amortization (CF) for Q1 2026 stood at $8000.0, down from $10000.0 in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $10000.0 in Q3 2025 and bottomed at $1000.0 in Q3 2022.
- The 5-year median for Depreciation & Amortization (CF) is $4500.0 (2023), against an average of $5000.0.
- The widest annual swing landed in 2024, when Depreciation & Amortization (CF) surged 350.0%; it then slipped 11.11% in 2025.
- A 5-year view of Depreciation & Amortization (CF) shows it stood at $2000.0 in 2022, then surged by 50.0% to $3000.0 in 2023, then jumped by 133.33% to $7000.0 in 2024, then surged by 42.86% to $10000.0 in 2025, then dropped by 20.0% to $8000.0 in 2026.
- The last three Depreciation & Amortization (CF) figures came in at $8000.0 (Q1 2026), $10000.0 (Q4 2025), and $10000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 1,395.22 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 55.90 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 123.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 13.55 Mn |
| 10 | Unicycive Therapeutics | 181.94 Mn | 127.36 Mn | - | 8,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8,000.00 |
| Mar 31, 2026 | 8,000.00 |
| Dec 31, 2025 | 10,000.00 |
| Dec 31, 2025 | 10,000.00 |
| Sep 30, 2025 | 10,000.00 |
| Sep 30, 2025 | 10,000.00 |
| Jun 30, 2025 | 6,000.00 |
| Jun 30, 2025 | 6,000.00 |
| Mar 31, 2025 | 8,000.00 |
| Mar 31, 2025 | 8,000.00 |
| Dec 31, 2024 | 7,000.00 |
| Dec 31, 2024 | 7,000.00 |
| Sep 30, 2024 | 6,000.00 |
| Sep 30, 2024 | 6,000.00 |
| Mar 31, 2024 | 9,000.00 |
| Mar 31, 2024 | 9,000.00 |
| Dec 31, 2023 | 3,000.00 |
| Dec 31, 2023 | 3,000.00 |
| Sep 30, 2023 | 2,000.00 |
| Sep 30, 2023 | 2,000.00 |
| Jun 30, 2023 | 2,000.00 |
| Jun 30, 2023 | 2,000.00 |
| Mar 31, 2023 | 2,000.00 |
| Mar 31, 2023 | 2,000.00 |
| Dec 31, 2022 | 2,000.00 |
| Dec 31, 2022 | 2,000.00 |
| Sep 30, 2022 | 1,000.00 |
| Sep 30, 2022 | 1,000.00 |
| Jun 30, 2022 | 2,000.00 |
| Jun 30, 2022 | 2,000.00 |
| Mar 31, 2022 | 2,000.00 |
| Mar 31, 2022 | 2,000.00 |